pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

14,388 catalysts · 3,350 8k filing · 2,435 grant · 2,379 approval · 1,691 device 510k · 1,229 device recall · 1,158 device pma

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 0 catalysts2026-08-13: 0 catalysts2026-08-14: 66 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2025-10-01×clear all
type
  • 8k filing3,350
  • grant2,435
  • approval2,379
  • device 510k1,691
  • device recall1,229
  • device pma1,158
device adverse event
1,000
  • earnings584
  • recall481
  • phase 2 completion172
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Sep 29, 2025

    50
    ›Oct 1, 2025grant318d agoRLR VA MEDICAL CENTER — Protective pathways in sepsis-induced renal injury

    VA grant. PI: Takashi Hato

    full page →nih reporter ↗
    ›Oct 1, 2025grant318d agoDARTMOUTH COLLEGE — Rapid innovation of precision psychiatry interventions using dynamic systems ...

    OD grant. $408,750. PI: Emily Kelley Presseller

    full page →nih reporter ↗
    ›Oct 1, 2025grant318d agoVA SAN DIEGO HEALTHCARE SYSTEM — Enhancing Veteran-Clinical Collaboration in VA Psychosocial Rehabilitation an...

    VA grant. PI: Emily Treichler

    full page →nih reporter ↗
    ›Oct 1, 2025grant318d agoNEW YORK UNIVERSITY — Addressing the Research Capacity Gap in Global Child, Adolescent, & Family He...New York University

    TW grant. $164,984. PI: Theresa Stichick Betancourt

    full page →nih reporter ↗
    ›Oct 1, 2025grant318d agoNORTHAMPTON VA MEDICAL CENTER — Re-animation of the eye with neodymium actuation system

    VA grant. PI: Kevin Edward Houston

    full page →nih reporter ↗
    ›Oct 1, 2025grant318d agoVA PUGET SOUND HEALTHCARE SYSTEM — Integrative genomic and environmental study to understand central sensitizati...

    VA grant. PI: Marianna Gasperi

    full page →nih reporter ↗
    ›Oct 1, 2025grant318d agoLOUIS STOKES CLEVELAND VA MEDICAL CENTER — Development of FES+BMI Neuroprosthesis for At-Home Use for Persons with Chron...

    VA grant. PI: ABIDEMI BOLU AJIBOYE

    full page →nih reporter ↗
    ›Oct 1, 2025grant318d agoMIAMI VA HEALTH CARE SYSTEM — Epigenetic and metabolic mechanisms of cadmium cytotoxicity

    VA grant. PI: David Benner Lombard

    full page →nih reporter ↗
    ›Oct 1, 2025grant318d agoRALPH H JOHNSON VA MEDICAL CENTER — Role of central amygdala dynorphin neurons in mediating chronic alcohol induc...

    VA grant. PI: Christina Lebonville

    full page →nih reporter ↗
    ›Oct 1, 2025grant318d agoRLR VA MEDICAL CENTER — Mechanisms of physioxia-dependent cancer cell adaptation to targeted drugs al...

    VA grant. PI: Harikrishna Nakshatri

    full page →nih reporter ↗
    ›Oct 1, 2025grant318d agoDURHAM VA MEDICAL CENTER — Using Community Health Workers to Support Rural Care Partners of Seriously Il...

    VA grant. PI: Nathan Adam Boucher

    full page →nih reporter ↗
    ›Oct 1, 2025grant318d agoOLIN TEAGUE VETERANS CENTER — A Randomized Controlled Trial of a Web-Based Moral Elevation Intervention for...

    VA grant. PI: Adam Patrick McGuire

    full page →nih reporter ↗
    ›Oct 1, 2025grant318d agoEDWARD HINES JR VA HOSPITAL — Biomarkers for Recovery of Veterans with Severe Spinal Cord Injury

    VA grant. PI: Monica A Perez

    full page →nih reporter ↗
    ›Oct 1, 2025grant318d agoVETERANS AFFAIRS MED CTR SAN FRANCISCO — Post-Hospitalization Virtual Care Among Veterans with Heart Failure: Examinin...

    VA grant. PI: Charlie M Wray

    full page →nih reporter ↗
    ›Oct 1, 2025grant318d agoEDITH NOURSE ROGERS MEMORIAL VETERANS HOSPITAL — The Development of a Transdiagnostic Intervention to Improve Social Functioni...

    VA grant. PI: Hannah Grigorian

    full page →nih reporter ↗
    ›Oct 1, 2025grant318d agoRLR VA MEDICAL CENTER — Developing a patient-centered intervention to improve exercise adoption and a...

    VA grant. PI: Sarah Shue

    full page →nih reporter ↗
    ›Oct 1, 2025grant318d agoPORTLAND VA MEDICAL CENTER — Exploring the Role of Central Auditory Processing in Spoken Language Comprehe...

    VA grant. PI: Marianne E Casilio

    full page →nih reporter ↗
    ›Oct 1, 2025grant318d agoPORTLAND VA MEDICAL CENTER — Glymphatics Imaging to Probe Sleep in Veterans with the Polytrauma Clinical T...

    VA grant. PI: Jonathan E Elliott

    full page →nih reporter ↗
    ›Oct 1, 2025grant318d agoST. LOUIS VA MEDICAL CENTER — Long-term Cardiometabolic Disease in COVID-19

    VA grant. PI: Ziyad Al-Aly

    full page →nih reporter ↗
    ›Oct 1, 2025grant318d agoUTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH — Innate Immunity to Viral Infection of the RetinaUniversity of Utah

    EY grant. $199,749. PI: Christopher Dale Conrady

    full page →nih reporter ↗
    ›Oct 2, 2025approval317d agoTECVAYLI (TECLISTAMAB-CQYV) — FDA approvalteclistamab

    Sponsor: JANSSEN BIOTECH. Form: INJECTABLE. Route: INJECTION

    full page →teclistamab →fda approvals ↗
    ›Oct 2, 2025approval317d agoTALVEY (TALQUETAMAB-TGVS) — FDA approvaltalquetamab

    Sponsor: JANSSEN BIOTECH. Form: INJECTABLE. Route: INJECTION

    full page →talquetamab →fda approvals ↗
    ›Oct 2, 2025approval317d agoZEPZELCA (LURBINECTEDIN) — FDA approvallurbinectedin

    Sponsor: JAZZ. Form: POWDER. Route: INTRAVENOUS

    full page →lurbinectedin →fda approvals ↗
    ›Oct 2, 2025approval317d agoTEPADINA AND SODIUM CHLORIDE (THIOTEPA) — FDA approvalRevalesio Corp

    Sponsor: ADIENNE SA. Form: POWDER. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Oct 2, 2025approval317d agoSCEMBLIX (ASCIMINIB HYDROCHLORIDE) — FDA approvalasciminib hydrochloride

    Sponsor: NOVARTIS. Form: TABLET. Route: ORAL

    full page →asciminib hydrochloride →fda approvals ↗
    ›Oct 2, 2025approval317d agoTECENTRIQ HYBREZA (ATEZOLIZUMAB AND HYALURONIDASE-TQJS) — FDA approval(atezolizumab + hyaluronidase (human recombinant))

    Sponsor: GENENTECH INC. Form: INJECTABLE. Route: INJECTION

    full page →(atezolizumab + hyaluronidase (human recombinant)) →fda approvals ↗
    ›Oct 2, 2025approval317d agoTECENTRIQ (ATEZOLIZUMAB) — FDA approvalatezolizumab

    Sponsor: GENENTECH INC. Form: INJECTABLE. Route: INJECTION

    full page →atezolizumab →fda approvals ↗
    ›Oct 2, 2025approval317d agoMETHYLIN ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalMETHYLIN ER

    Sponsor: SPECGX LLC. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →METHYLIN ER →fda approvals ↗
    ›Oct 2, 2025approval317d agoCROMOLYN SODIUM — FDA approvalVitalgenics LLC

    Sponsor: TEVA PHARMS. Form: SOLUTION. Route: INHALATION

    full page →fda approvals ↗
    ›Oct 2, 2025approval317d agoMETADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalMETADATE ER

    Sponsor: LANNETT CO INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →METADATE ER →fda approvals ↗
    ›Oct 2, 2025approval317d agoMETADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalMETADATE ER

    Sponsor: LANNETT CO INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →METADATE ER →fda approvals ↗
    ›Oct 2, 2025approval317d agoEYDENZELT (AFLIBERCEPT-BOAV) — FDA approvalEYDENZELT

    Sponsor: CELLTRION INC. Form: INJECTABLE. Route: INJECTION

    full page →EYDENZELT →fda approvals ↗
    ›Oct 2, 2025approval317d agoSEVOFLURANE — FDA approvalSEVOFLURANE

    Sponsor: BAXTER HLTHCARE. Form: LIQUID. Route: INHALATION

    full page →SEVOFLURANE →fda approvals ↗
    ›Oct 2, 2025approval317d agoLABETALOL HYDROCHLORIDE — FDA approvalLABETALOL HYDROCHLORIDE

    Sponsor: AMNEAL. Form: INJECTABLE. Route: INJECTION

    full page →LABETALOL HYDROCHLORIDE →fda approvals ↗
    ›Oct 2, 2025approval317d agoVANCOMYCIN HYDROCHLORIDE — FDA approvalSamson Medical Technologies LLC

    Sponsor: STERISCIENCE. Form: POWDER. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Oct 2, 2025approval317d agoLIDOCAINE HYDROCHLORIDE — FDA approvalInternational Medication Systems Ltd

    Sponsor: ANTHEA PHARMA. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Oct 2, 2025approval317d agoPILOCARPINE HYDROCHLORIDE — FDA approvalPILOCARPINE HYDROCHLORIDE

    Sponsor: FDC LTD. Form: SOLUTION/DROPS. Route: OPHTHALMIC

    full page →PILOCARPINE HYDROCHLORIDE →fda approvals ↗
    ›Oct 2, 2025approval317d agoOSELTAMIVIR PHOSPHATE — FDA approvalF. Hoffmann-La Roche Ltd

    Sponsor: ZHEJIANG POLY PHARM. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Oct 2, 2025approval317d agoMIRTAZAPINE — FDA approvalmirtazapine ODT

    Sponsor: ANNORA PHARMA. Form: TABLET. Route: ORAL

    full page →mirtazapine ODT →fda approvals ↗
    ›Oct 2, 2025approval317d agoOLANZAPINE — FDA approvalTEVA PHARMACEUTICAL INDUSTRIES LTD

    Sponsor: CHARTWELL MOLECULAR. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL

    full page →fda approvals ↗
    ›Oct 2, 2025approval317d agoOLANZAPINE — FDA approvalTEVA PHARMACEUTICAL INDUSTRIES LTD

    Sponsor: CHARTWELL MOLECULAR. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL

    full page →fda approvals ↗
    ›Oct 2, 2025approval317d agoETRAVIRINE — FDA approvalETRAVIRINE

    Sponsor: BIONPHARMA. Form: TABLET. Route: ORAL

    full page →ETRAVIRINE →fda approvals ↗
    ›Oct 2, 2025device 510k317d agoShenzhen Enmind Technology Co., Ltd. — IPL Hair Removal Device (IPL-001, IPL-002) (510k cleared)Fortior Technology (Shenzhen) Co., Ltd./ADR

    Product code: OHT. Advisory committee: General, Plastic Surgery. Type: Traditional

    full page →fda device 510k ↗
    ›Oct 2, 2025device 510k317d agoNingbo Tianyi Medical Appliance Co., Ltd. — TIANYI Extracorporeal Blood Tubing Set (TY-NDEO-A1) (510k cleared)

    Product code: FJK. Advisory committee: Gastroenterology, Urology. Type: Traditional

    full page →fda device 510k ↗
    ›Oct 2, 2025device 510k317d agoGC America, Inc. — G-Bond Universal (510k cleared)PARKS AMERICA, INC

    Product code: KLE. Advisory committee: Dental. Type: Traditional

    full page →fda device 510k ↗
    ›Oct 2, 2025device 510k317d agoPhilips Medical Systems Nederland B.V. — Philips IntelliSpace Cardiovascular (510k cleared)

    Product code: LLZ. Advisory committee: Radiology. Type: Traditional

    full page →fda device 510k ↗
    ›Oct 2, 2025device 510k317d agoShenzhen Finicare Co., Ltd. — Upper Arm Electronic Blood Pressure Monitor (FC-BP107, FC-BP123, FC-BP125, FC-BP126, FC-BP127, FC-BP116) (510k cleared)

    Product code: DXN. Advisory committee: Cardiovascular. Type: Special

    full page →fda device 510k ↗
    ›Oct 2, 2025device 510k317d agoSimergent, LLC — Archimedes Pro Automated Peritoneal Dialysis Cycler (3014-00000-1); Archimedes Standard Automated Peritoneal Dialysis Cycler (3014-00000-3); Archimedes Pro Disposable Tubing Set (3014-50000-1); Archimedes Standard Disposable Tubing Set (3014-50000-3); Archimedes Pro Plus Disposable Tubing Set (3014-50000-5) (510k cleared)

    Product code: FKX. Advisory committee: Gastroenterology, Urology. Type: Traditional

    full page →fda device 510k ↗
    ›Oct 2, 2025device 510k317d agoThirona BV — LungQ 4 (510k cleared)

    Product code: JAK. Advisory committee: Radiology. Type: Traditional

    full page →fda device 510k ↗
    ›Oct 2, 2025device 510k317d agoLiofilchem s.r.l. — MTS Aztreonam-Avibactam 0.016/4 - 256/4 µg/mL (510k cleared)Bristol-Myers Squibb Co

    Product code: JWY. Advisory committee: Microbiology. Type: Traditional

    full page →fda device 510k ↗
    ← prev
    page 3 of 288
    next →
    $FRTRY
    $JAZZ244.96-0.36%
    $TEVA36.77+0.68%
    $TEVA36.77+0.68%
    $AMRX18.15+5.10%
    $PRKA
    $NVS150.88-0.55%